Full-Time

Senior Manager

Molecular Pathology

Posted on 12/21/2024

Altos Labs

Altos Labs

501-1,000 employees

Biotechnology focused on cell rejuvenation research

Biotechnology
Healthcare

Compensation Overview

$215.9k - $292.1kAnnually

Senior

San Diego, CA, USA

UK Citizenship Required

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis

You match the following Altos Labs's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD in Molecular Biology, Genetics, Biochemistry, or a related field.
  • Proven 8+ years of experience in molecular biology techniques and data analysis.
  • 5+ years of experience managing molecular pathology laboratory
  • Strong background in pathology, particularly in the mechanisms of disease at the molecular level.
  • Excellent problem-solving skills and the ability to work independently as well as part of a team
  • Strong communication skills, both written and verbal, are essential.
Responsibilities
  • Create molecular pathology workflows to ensure timely delivery of high-quality IND-enabling data packages while assuring compliance with all relevant regulatory reporting and data integrity requirements
  • Manage cross-functional study teams and workflows that integrate histology, microscopy, pathology, and computational sciences to ensure seamless generation of high-quality molecular pathology data and study reports
  • Lead growth and strategic implementation molecular platforms (spatial digital pathology, high-multiplexing staining, and microscopic image analysis) to enable delivery of the Altos Labs portfolio
  • Oversees all molecular pathology work for IoM, including selecting and managing CROs and CLIA certified labs for assay development.
  • Design and conduct experiments related to molecular pathology using techniques such as immunohistochemistry (single and multiplex), in situ hybridization, laser capture microdissection, PCR, RT-qPCR, Western blotting, spatial transcriptomics, and next-generation sequencing
  • Collaborate with multidisciplinary teams to integrate molecular findings with preclinical and translational safety data
  • Develop and validate new molecular diagnostic tests and biomarkers for various diseases and deliver therapeutic target expression profiling data packages
  • Analyze and interpret data from molecular and cellular experiments
  • Stay updated with the latest scientific advancements in molecular pathology and related fields
  • Mentor and supervise junior scientists and technicians
  • Build molecular pathology team as needed to match portfolio and workload needs.
Desired Qualifications
  • Experience in aging research, cellular senescence, or related areas
  • Familiarity with computational biology and bioinformatics tools

Altos Labs specializes in biotechnology with a focus on cell rejuvenation, aiming to restore cell health and resilience to reverse diseases and injuries. They utilize cellular rejuvenation programming to enhance cells' ability to resist stressors that lead to illness. Unlike competitors, Altos Labs emphasizes scientific research and collaboration with healthcare providers and pharmaceutical companies to develop breakthrough treatments. Their goal is to improve patients' quality of life by providing effective solutions for various health conditions.

Company Size

501-1,000

Company Stage

Seed

Total Funding

$3.2B

Headquarters

Los Altos, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Significant funding of $270 million supports Altos Labs' research and development efforts.
  • The economic potential of increased life expectancy is recognized as a major opportunity.
  • Collaborations with tech industry veterans accelerate innovation and commercialization.

What critics are saying

  • Ethical concerns about lifespan extension may lead to regulatory challenges.
  • Intensifying competition in the biotechnology sector could dilute market share.
  • High expectations from financial backers may pressure the company to deliver quickly.

What makes Altos Labs unique

  • Altos Labs focuses on cellular rejuvenation to reverse diseases and improve health.
  • The company integrates computational biology and CRISPR technology for innovative solutions.
  • Altos Labs collaborates with leading scientists, including Nobel laureate Jennifer Doudna.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
The Spirits Business
Mar 27th, 2024
Altos is UK off-trade's leading 100% agave Tequila

In London, Altos recently launched its inaugural Margarita Masters competition for bartenders, with the hope of taking it nationwide in the future.

Startup Italia
Nov 17th, 2023
«Ad Altos Labs Vogliamo Creare Una Nuova Medicina». Simone Bianco E L’Avventura Nella Venture Californiana

«Per uno scienziato Elon Musk ha senz’altro meno appeal di un Premio Nobel». Se poi i Nobel sono quattro, tutti seduti nel board of directors della startup per cui lavori, potremmo dire non esserci partita. Tra questi, ad esempio, Jennifer Doudna, che ha vinto grazie al lavoro sull’editing genetico Crispr nel 2020. Simone Bianco, employee numero 27 di Altos Labs con sede a San Francisco, è Principal Investigator e Director of Computational Biology in quella che lui preferisce definire una venture, non una startup. Nel corso dell’intervista gli abbiamo chiesto di Musk e dei suoi piani per salvare l’umanità, anche con Neuralink, ma la discussione ha rapidamente virato verso altre figure, più specializzate nella materia in questione. Altos Labs, dunque

The Recursive
Mar 8th, 2023
Finding The Fountain Of Youth: Meet The Startups Pioneering Longevity Solutions

If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one of our readers – they would want to live forever, yet only if they stayed young. Among others, living long worries people as it is associated with getting old and suffering from various diseases.Yet if technology allows us to extend our life spans it will also likely improve our health spans. According to demographers, children today have a better chance of living up to 100 years old than ever before. But their lives won’t be just longer, they will also benefit from day-to-day technological advances aimed at improving their well-being, preventing diseases, and keeping their minds and bodies in shape.Slowing aging presents an economic opportunity, too. In the US, an estimate shows that just one to two years increase in life expectancy are worth between $7 trillion and $38 trillion

GeekWire
Apr 21st, 2022
Juno Therapeutics Vets Steve Harr And Hans Bishop On Building Startups, Working With Tech, And More

Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell therapy company Juno Therapeutics, where Bishop was CEO and Harr was COO and CFO.

Fierce Biotech
Apr 18th, 2022
Biotech's top 10 money raisers of 2021

After a bustling, record-setting 2020 for private biotechs raising cash, the bar heading into 2021 was exceptionally high. Turns out, private investors elected to just take the bar and do pull-ups, breaking 2020’s record by a whopping 26%.  | 2021 marked the second consecutive year of record-breaking private financing for biotechs, with more than $28 billion raised. The total haul is a 26% increase from 2020, and the stunning dollar amounts came even as the public market depreciated throughout the year. Here's our look at the 10 biotechs that raked in the largest VC investments.

INACTIVE